Indonesian Company, Afi Farma Officials Jailed Over Deadly Cough Syrup

Jakarta: An Indonesian court sentenced to jail on Wednesday the CEO and three other officials of a company whose cough syrup has been linked to the death of more than 200 children, for violating drug safety laws, the company’s lawyer said.

The Indonesian company, Afi Farma, was accused of producing cough syrups containing excess amounts of toxic material. Prosecutors charged the four officials for “consciously” not testing the ingredients, despite having the means and responsibility to do so, according to the charge sheet.

The company’s lawyer, Reza Wendra Prayogo, said they deny negligence and the company is considering whether to appeal.

The officials, including CEO Arief Prasetya Harahap, were sentenced to two years in prison by a court in the town of Kediri, in East Java province, where the company is based.

Prosecutors, who had sought up to nine years in prison for the accused, said that Afi Farma did not test the ingredients sent by its supplier and instead relied on certificates provided by them regarding product quality and safety.

Reza said in October that Indonesia’s drug regulator, BPOM, did not require drugmakers to do rigorous testing of ingredients.

The case comes as efforts grow worldwide to tighten oversight of drug supply chains after a wave of poisonings linked to contaminated cough syrups that killed dozens of children in countries such as Gambia and Uzbekistan.

Related Posts

  • Pharma
  • December 23, 2024
  • 63 views
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

  • Pharma
  • December 23, 2024
  • 89 views
NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

India-Latin America trade and collaboration prospects discussed at Kerala University conference

India-Latin America trade and collaboration prospects discussed at Kerala University conference

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt